About Firm News
In the News
Kyle Sampson comments on FDA drug approvals slowing down as a result of budget cuts and the government shutdown
October 21, 2025
| PharmaCircle
Featured Lawyers:
Person Dennis Sampson
D. Kyle Sampson
Partner

Go to the article

Related Capabilities
Innovative Drug, Biologic & Device Development Special Matters & Government Investigations FDA & Life Sciences
Featured Lawyers
Person Dennis Sampson
D. Kyle Sampson
Partner
Government Matters & Regulation
Explore King & Spalding
a blue and green background
Capabilities
Innovative Drug, Biologic & Device Development
Learn More
a blue and green background
Capabilities
Special Matters & Government Investigations
Learn More